Oppenheimer Asset Management Inc. Novo Nordisk A S Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 393,234 shares of NVO stock, worth $41.3 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

393,234

Previous 389,476 0.96%

Holding current value

$41.3 Million

Previous $55.6 Million 15.78%

% of portfolio

0.58%

Previous 0.73%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$119.07 - $145.42 $447,465 - $546,488	3,758 Added 0.96%	393,234 $46.8 Million
Q2 2024 Aug 08, 2024	BUY	$122.71 - $146.91 $5.52 Million - $6.61 Million	44,981 Added 13.06%	389,476 $55.6 Million
Q1 2024 May 06, 2024	SELL	$102.11 - $135.92 $5.88 Million - $7.82 Million	-57,561 Reduced 14.32%	344,495 $44.2 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $597,606 - $717,903	6,808 Added 1.72%	402,056 $41.6 Million
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $21.7 Million - $47.7 Million	239,042 Added 153.03%	395,248 $35.9 Million
Q2 2023 Aug 02, 2023	SELL	$155.98 - $172.65 $906,399 - $1 Million	-5,811 Reduced 3.59%	156,206 $25.3 Million
Q1 2023 May 10, 2023	SELL	$132.34 - $159.14 $7.11 Million - $8.55 Million	-53,705 Reduced 24.9%	162,017 $25.8 Million
Q4 2022 Feb 06, 2023	SELL	$102.55 - $135.33 $1.79 Million - $2.36 Million	-17,447 Reduced 7.48%	215,722 $29.2 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $575,777 - $706,607	6,043 Added 2.66%	233,169 $23.2 Million
Q2 2022 Aug 08, 2022	SELL	$103.24 - $121.81 $948,878 - $1.12 Million	-9,191 Reduced 3.89%	227,126 $25.3 Million
Q1 2022 May 12, 2022	BUY	$93.1 - $112.54 $209,288 - $252,989	2,248 Added 0.96%	236,317 $26.2 Million
Q4 2021 Feb 02, 2022	BUY	$95.88 - $117.08 $275,750 - $336,722	2,876 Added 1.24%	234,069 $26.2 Million
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $5.64 Million - $7.12 Million	-66,765 Reduced 22.41%	231,193 $22.2 Million
Q2 2021 Aug 03, 2021	BUY	$67.66 - $84.76 $4,465 - $5,594	66 Added 0.02%	297,958 $25 Million
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $1.91 Million - $2.16 Million	28,539 Added 10.6%	297,892 $20.1 Million
Q4 2020 Feb 11, 2021	BUY	$63.89 - $73.8 $1.06 Million - $1.22 Million	16,572 Added 6.56%	269,353 $18.8 Million
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $1.03 Million - $1.14 Million	16,205 Added 6.85%	252,781 $17.6 Million
Q2 2020 Aug 11, 2020	SELL	$58.54 - $67.94 $980,252 - $1.14 Million	-16,745 Reduced 6.61%	236,576 $15.5 Million
Q1 2020 May 08, 2020	BUY	$49.46 - $64.78 $1.17 Million - $1.54 Million	23,698 Added 10.32%	253,321 $15.3 Million
Q4 2019 Feb 07, 2020	BUY	$49.86 - $58.26 $458,063 - $535,234	9,187 Added 4.17%	229,623 $13.3 Million
Q3 2019 Oct 31, 2019	BUY	$47.54 - $53.43 $919,376 - $1.03 Million	19,339 Added 9.62%	220,436 $11.4 Million
Q2 2019 Aug 09, 2019	BUY	$46.79 - $52.47 $1.05 Million - $1.18 Million	22,500 Added 12.6%	201,097 $10.3 Million
Q1 2019 Apr 24, 2019	BUY	$46.36 - $52.63 $1.06 Million - $1.2 Million	22,809 Added 14.64%	178,597 $9.34 Million
Q4 2018 Jan 30, 2019	BUY	$41.54 - $47.25 $291,029 - $331,033	7,006 Added 4.71%	155,788 $7.18 Million
Q3 2018 Oct 26, 2018	BUY	$46.76 - $51.24 $1.83 Million - $2 Million	39,049 Added 35.59%	148,782 $7.01 Million
Q2 2018 Aug 10, 2018	BUY	$44.29 - $50.42 $368,714 - $419,746	8,325 Added 8.21%	109,733 $5.06 Million
Q1 2018 May 09, 2018	BUY	$48.49 - $58.14 $1.49 Million - $1.79 Million	30,764 Added 43.55%	101,408 $5 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $2.91 Million - $3.48 Million	70,644	70,644 $3.4 Million

Others Institutions Holding NVO

# of Institutions

1,954

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Novo Nordisk A S Transaction History